Medidata Solutions Inc (MDSO):企業の財務・戦略的SWOT分析

◆英語タイトル:Medidata Solutions Inc (MDSO) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15490
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Medidata Solutions Inc (MDSO) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data and analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analytics solutions, using secure cloud and hybrid cloud infrastructure. Medidata’s service portfolio includes implementation, configuration, data testing, and integration support, training, reporting and consultation services for clinical development process. Medidata offers its services to pharmaceutical, biotechnology and medical device companies, academic institutions, and contract research organizations (CROs). The company markets and sells its products through direct sales force, CROs and strategic partners in North America, Europe and Asia. Medidata is headquartered in New York, the US.

Medidata Solutions Inc Key Recent Developments

Feb 12,2019 Medidata reports fourth quarter 2018 results
Feb 11,2019 Medidata and Cognizant form strategic alliance to make digital transformation accessible for the life sciences
Jan 22,2019 Medidata introduces new collaborative workspace for sites, sponsors, and CROs to manage TMF content
Jan 07,2019 Medidata names Sastry Chilukuri as executive vice president of Digital and AI Solutions

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Medidata Solutions Inc – Key Facts
Medidata Solutions Inc – Key Employees
Medidata Solutions Inc – Key Employee Biographies
Medidata Solutions Inc – Major Products and Services
Medidata Solutions Inc – History
Medidata Solutions Inc – Company Statement
Medidata Solutions Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Medidata Solutions Inc – Business Description
Business Segment: Professional Services
Overview
Performance
Business Segment: Subscription Services
Overview
Performance
Key Stats
Geographical Segment: Americas
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Medidata Solutions Inc – Corporate Strategy
Medidata Solutions Inc – SWOT Analysis
SWOT Analysis – Overview
Medidata Solutions Inc – Strengths
Medidata Solutions Inc – Weaknesses
Medidata Solutions Inc – Opportunities
Medidata Solutions Inc – Threats
Medidata Solutions Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Medidata Solutions Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Medidata Solutions Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 12, 2019: Medidata reports fourth quarter 2018 results
Feb 11, 2019: Medidata and Cognizant form strategic alliance to make digital transformation accessible for the life sciences
Jan 22, 2019: Medidata introduces new collaborative workspace for sites, sponsors, and CROs to manage TMF content
Jan 07, 2019: Medidata names Sastry Chilukuri as executive vice president of Digital and AI Solutions
Dec 04, 2018: Medidata Rave Omics collaboration uncovers novel insights for rare disease research
Nov 30, 2018: Medidata Rave Engage Wins Scrip Award for Best Sponsor-Focused Technological Development in Clinical Trials
Nov 29, 2018: Federal Court rejects Veeva’s attack on Medidata’s theft of trade secret claims
Nov 20, 2018: Two research studies supported by Medidata to be presented at ASH 2018
Nov 15, 2018: Hengrui Pharma partners with Medidata to accelerate global drug research
Nov 08, 2018: PAREXEL and SHYFT Analytics partner to deliver faster, more dynamic real-world data studies
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Medidata Solutions Inc, Key Facts
Medidata Solutions Inc, Key Employees
Medidata Solutions Inc, Key Employee Biographies
Medidata Solutions Inc, Major Products and Services
Medidata Solutions Inc, History
Medidata Solutions Inc, Other Locations
Medidata Solutions Inc, Subsidiaries
Medidata Solutions Inc, Key Competitors
Medidata Solutions Inc, Ratios based on current share price
Medidata Solutions Inc, Annual Ratios
Medidata Solutions Inc, Annual Ratios (Cont...1)
Medidata Solutions Inc, Annual Ratios (Cont...2)
Medidata Solutions Inc, Interim Ratios
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Medidata Solutions Inc, Medical Equipment, Deals By Type, 2013 to YTD 2019
Medidata Solutions Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Medidata Solutions Inc, Performance Chart (2014 - 2018)
Medidata Solutions Inc, Ratio Charts
Medidata Solutions Inc, Medical Equipment, Deals By Year, 2013 to YTD 2019
Medidata Solutions Inc, Medical Equipment, Deals by Type, 2013 to YTD 2019

★海外企業調査レポート[Medidata Solutions Inc (MDSO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EnerVest Ltd:企業のM&A・事業提携・投資動向
    EnerVest Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnerVest Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • HTC Corporation:企業の戦略・SWOT・財務情報
    HTC Corporation - Strategy, SWOT and Corporate Finance Report Summary HTC Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Peabody Energy Corp:企業の戦略・SWOT・財務分析
    Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report Summary Peabody Energy Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Rosenergoatom Concern JSC:企業の戦略的SWOT分析
    Rosenergoatom Concern JSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Enmax Corporation:発電所・企業SWOT分析
    Enmax Corporation – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Qurient Co Ltd (115180):製薬・医療:M&Aディール及び事業提携情報
    Summary Qurient Co Ltd (Qurient) is a pharmaceutical company that offers development of new drugs for unmet medical needs. The company provides portfolio of pipeline products such as Q301, Q203, Q701, 5LO INH and CDK7 INH, among others. It is developing products for the treatment of atopic dermatiti …
  • Chorus Aviation Inc.:戦略・SWOT・企業財務分析
    Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report Summary Chorus Aviation Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AMAG Pharmaceuticals Inc (AMAG):医療機器:M&Aディール及び事業提携情報
    Summary AMAG Pharmaceuticals Inc (AMAG) develops and commercializes specialty pharmaceutical products with focus on maternal health, anemia management and cancer supportive care. It develops and markets products used to reduce the risk of preterm birth in women with a single baby who have a history …
  • SR Technics Holding:企業の戦略的SWOT分析
    SR Technics Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • China State Construction International Holdings Limited:戦略・SWOT・企業財務分析
    China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary China State Construction International Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • Interconexion Electrica SA ESP (ISA):企業の財務・戦略的SWOT分析
    Interconexion Electrica SA ESP (ISA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Amazon.com Inc (AMZN):企業の財務・戦略的SWOT分析
    Amazon.com Inc (AMZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fate Therapeutics Inc (FATE)-製薬・医療分野:企業M&A・提携分析
    Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company’s pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidate …
  • Agilent Technologies Inc (A):企業の財務・戦略的SWOT分析
    Agilent Technologies Inc (A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ionis Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Ionis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • 3SBio Inc (1530):製薬・医療:M&Aディール及び事業提携情報
    Summary 3SBio Inc (3SBio) is a biotechnology companies that carries out the research, development, manufacturing and marketing of biopharmaceutical products. It develops recombinant, or genetically engineered, protein-based products and other pharmaceutical product candidates to address large market …
  • Astea International Inc (ATEA):企業の財務・戦略的SWOT分析
    Summary Astea International Inc (Astea) is a technology company that offers end-to-end service management software solutions. The company offers products such as Astea Alliance and FieldCentrix. Its FieldCentrix is used in paper-based operation, optimizes service resources, and provides standardized …
  • Apollo Global Management Inc:企業の戦略・SWOT・財務分析
    Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report Summary Apollo Global Management Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Novo Nordisk AS (NOVO B):製薬・医療:M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • SK Biopharmaceuticals Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a researcher and developer of drugs. The company develops and markets drugs for the treatment of central nervous system. It provides plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL-A4R …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆